Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 180,600
-200 (-0.11%)
At close: Dec 19, 2025
Daewoong Pharmaceutical Market Cap
Daewoong Pharmaceutical has a market cap or net worth of 2.08 trillion as of December 19, 2025. Its market cap has increased by 39.89% in one year.
Market Cap
2.08T
Enterprise Value
2.82T
Revenue
1.54T
Ranking
n/a
PE Ratio
22.30
Stock Price
180,600.00
Market Cap Chart
Since March 12, 2003, Daewoong Pharmaceutical's market cap has increased from 131.88B to 2.08T, an increase of 1,475.72%. That is a compound annual growth rate of 12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.08T | 42.88% |
| Dec 30, 2024 | 1.45T | 8.22% |
| Dec 28, 2023 | 1.34T | -23.40% |
| Dec 29, 2022 | 1.75T | 7.09% |
| Dec 30, 2021 | 1.64T | -7.75% |
| Dec 30, 2020 | 1.78T | 25.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.93T |
| ALTEOGEN | 23.05T |
| SK Biopharmaceuticals | 10.26T |
| ABL Bio | 10.04T |
| Yuhan | 8.52T |
| LigaChem Biosciences | 6.14T |
| HLB Co., Ltd. | 6.05T |